PERCUTANEOUS BURR
Report
- Report Number
- 3010470577-2021-05151
- Event Type
- Malfunction
- Date Received
- June 16, 2021
- Date of Event
- May 11, 2021
- Report Date
- August 5, 2021
- Manufacturer
- IN2BONES SAS
- Product Code
- GFF
- PMA / PMN Number
- EXEMPT
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FR
- Reporter Occupation
- PHARMACIST
Narratives
DURING AN OSTEOTOMY OF THE FOOT 1ST METATARSAL, 2 PERCUTANEOUS BURRS USED TO WORK ON THE BONE BROKE. A SIGNIFICANT DELAY IN SURGERY DURATION WAS REPORTED, NO OTHER CLINICAL CONSEQUENCES ARE KNOWN TO DATE. PRELIMINARY INVESTIGATION SHOWED THAT THE BATCH RECORD WAS COMPLIANT. OCCURRENCE OF THE EVENT WHEN THE FIRST REPORT WAS WRITTEN WAS OF 0,98% ; THE WORST-CASE CONSEQUENCE FOR THE PATIENT IS A SIGNIFICANT DELAY IN SURGERY DURATION. THE TWO DEVICES WERE RETURNED TO IN2BONES THE 25/MAY/2021 AND SENT TO THE MANUFACTURING SUBCONTRACTOR FOR ANALYSIS ; AFTER DESTRUCTIVE TESTING PERFORMED THE 26/MAY/2021, THE 2 BURRS WERE FOUND TO BE COMPLIANT TO SPECIFICATIONS. TO DATE (AUGUST 2021), NO NEW OCCURRENCE OF BREAKAGE WAS RECORDED SINCE THIS EVENT WAS REPORTED. OCCURRENCE OF THE EVENT IS NOW OF 0,83%. THIS BURR REFERENCE WAS SUBJECT TO A CHANGE CONTROL (DM2102-04), TO ADJUST THE DRAWINGS MANUFACTURING TOLERANCE TO PREVENT BREAKAGES FROM OCCURING AGAIN. OCCURRENCE OF THE EVENT ON BURRS BATCHES SOLD AFTER THE CHANGE CONTROL ONLY IS OF 0,55%. THE CURRENT RISK MANAGEMENT FILE IS ALIGNED WITH THIS ASSESSMENT. THIS IS THE FIRST AND ONLY REPORTING OF BREAKAGES SINCE THE CHANGE CONTROL WAS FINALIZED THE 19TH OF APRIL 2021. GIVEN THAT DESTRUCTIVE TESTING PERFORMED CONCLUDED THAT THE DEVICES WERE COMPLIANT TO SPECIFICATIONS, AND THAT THE OCCURENCE IS RARE (<1%), THE MOST PROBABLE ROOT CAUSE IS UNINTENDED USE ERROR WITH EXCESSIVE FORCE APPLIED ON THE BURR. IN2BONES WILL CONTINUE TO CLOSELY MONITOR THIS TYPE OF EVENTS.
DURING AN OSTEOTOMY OF THE FOOT 1ST METATARSAL, 2 PERCUTANEOUS BURRS USED TO WORK ON THE BONE BROKE. A SIGNIFICANT DELAY IN SURGERY DURATION WAS REPORTED, NO OTHER CLINICAL CONSEQUENCES ARE KNOWN TO DATE. PRELIMINARY INVESTIGATION SHOWED THAT THE BATCH RECORD WAS COMPLIANT. OCCURRENCE OF THE EVENT IS OF 0,98% ; THE WORST-CASE CONSEQUENCE FOR THE PATIENT IS A SIGNIFICANT DELAY IN SURGERY DURATION. THE TWO DEVICES WERE RETURNED TO IN2BONES THE (B)(6) 2021 AND SENT TO THE MANUFACTURING SUBCONTRACTOR FOR ANALYSIS ; AFTER DESTRUCTIVE TESTING PERFORMED THE (B)(6) 2021, THE 2 BURRS WERE FOUND TO BE COMPLIANT TO SPECIFICATIONS. INVESTIGATION AND ROOT CAUSE DETERMINATION ARE STILL IN PROGRESS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 910111 | PERCUTANEOUS BURR | PERCUTANEOUS BURR, | GFF | IN2BONES SAS | G01 01512 | 2104006 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 61 YR | Other |